Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings) - Image 1

£76.77

Springer Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

Name: Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)
Brand: Springer
Price: 76.77 GBP
Availability: InStock

Diseases & Disorders

This is the most expensive it has ever been. Walk away.

£77 today · previous high £77 · all-time low £77

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price

Price Analysis

Most common price: £77 (64 days, 100.0%)

Price range: £77 - £77

Price levels: 1 different prices over 64 days

Description

The renewal of interest in excitatory amino acids in the 1980s has altered the direction of neurobiology. L-Glutamate, widely regarded as a general perpetu ator of nonspecific excitation, has become generally regarded as a widely dis tributed and important neurotransmitter in the CNS. In the past three decades evidence has accumulated that excitatory amino acids are involved in many neurological diseases and that pharmacological intervention may offer pros pects of novel and more effective therapies. Numerous studies on experimen tal animals demonstrate that excitatory amino acid antagonists have anxio lytic, antiepileptic and muscle relaxant effects. Particular interest has developed in the possible neuroprotective efficacy of excitatory amino acid receptor antagonists in neurological diseases such as hypoxia/ischemia, hypo glycemia, epilepsy, and chronic neurodegenerative disorders (Huntington's, Alzheimer's, and Parkinson's disease, amyotrophic lateral sclerosis, and AIDS). Thus, the drugs changing neurotransmission mediated by excitatory amino acids possess potential therapeutic value. This volume is part of the Schering Research Foundation Workshop Series. It is the goal of the Schering Research Foundation to promote the asso ciation between industrial and basic research. The support and the organiza tion of highly qualified symposia belong to the armamentarium by which this purpose is fulfilled, and we are convinced that the workshop "Excitatory Amino Acids and Second Messenger Systems" has contributed to this. Gunter Stock Ursula-F.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3662226685
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 23 August 2014
Listed Since: 06 August 2014

Barcode

No barcode data available

Springer Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Nicotinic Acetycholine Receptors – From Molecular Biology to Cognition

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

International Review of Neurobiology: Vol 54: Volume 54

Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)

Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)

Receptor-Receptor Interactions in the Central Nervous System: 140 (Neuromethods, 140)

Advances in Neuropharmacology: Drugs and Therapeutics

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Neurochemistry: Molecular and Cellular Clinical Applications

Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)

Amines and Their Metabolites: 2 (Neuromethods, 2)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Purinergic Signaling in Neuroinflammation

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)